AI assistant
HALLIBURTON CO — Director's Dealing 2003
Aug 4, 2003
30269_dirs_2003-08-04_111b7d94-d831-414a-b4b4-3a5696ac94f5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HALLIBURTON CO (HAL)
CIK: 0000045012
Period of Report: 2003-07-31
Reporting Person: DERR KENNETH T (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2003-08-01 | Common Stock | A | 1800 | — | Acquired | 5600 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2003-07-31 | Stock Equivalent Units | $ | A | 531.5 | Acquired | Common Stock (531.5) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option to Buy Common Stock | $45.35 | 2011-05-05 | Common Stock (5000) | 5000 | Direct |
| Option to Buy Common Stock | $16.75 | 2012-05-15 | Common Stock (2000) | 2000 | Direct |
Footnotes
F1: 400 shares awarded pursuant to Halliburton Company's Restricted Stock Plan for Non-Employee Directors. 1400 shares awarded pursuant to Halliburton Company's 1993 Stock and Incentive Plan.
F2: On August 1, 2003, the closing price of Halliburton Company Common Stock on the New York Stock Exchange was $22.24 per share.
F3: The security converts to common stock on a one-for-one basis.
F4: Stock equivalents acquired under Halliburton Company's Directors' Deferred Compensation Plan reported on a pro rata basis to reflect Issuer's Plan quarter. Said Plan is an ongoing securities acquisition plan.
F5: The stock equivalent units were accrued under the Company's Directors' Deferred Compensation Plan and are settled in the Company's common stock upon cessation as a director.
F6: On July 30, 2003, the closing price of Halliburton Company Common Stock on the New York Stock Exchange was $21.11 per share.
F7: Options are exercisable six months after the date of grant.